These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16341143

  • 1. Th2-dominated antitumor immunity induced by DNA immunization with the genes coding for a basal core peptide PDTRP and GM-CSF.
    Chu Y, Xia M, Lin Y, Li A, Wang Y, Liu R, Xiong S.
    Cancer Gene Ther; 2006 May; 13(5):510-9. PubMed ID: 16341143
    [Abstract] [Full Text] [Related]

  • 2. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 3. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE, Zhang J, Whitton JL.
    Virology; 1999 Oct 10; 263(1):175-83. PubMed ID: 10544092
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 10; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 5. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C, Peng G, Jin X, Tang J, Chen Z.
    Clin Immunol; 2010 Nov 10; 137(2):190-8. PubMed ID: 20692873
    [Abstract] [Full Text] [Related]

  • 6. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.
    Weiss WR, Ishii KJ, Hedstrom RC, Sedegah M, Ichino M, Barnhart K, Klinman DM, Hoffman SL.
    J Immunol; 1998 Sep 01; 161(5):2325-32. PubMed ID: 9725227
    [Abstract] [Full Text] [Related]

  • 7. A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice.
    Snyder LA, Goletz TJ, Gunn GR, Shi FF, Harris MC, Cochlin K, McCauley C, McCarthy SG, Branigan PJ, Knight DM.
    Vaccine; 2006 Apr 12; 24(16):3340-52. PubMed ID: 16472547
    [Abstract] [Full Text] [Related]

  • 8. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.
    Yo YT, Hsu KF, Shieh GS, Lo CW, Chang CC, Wu CL, Shiau AL.
    Cancer Gene Ther; 2007 Nov 12; 14(11):904-17. PubMed ID: 17704754
    [Abstract] [Full Text] [Related]

  • 9. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
    Zhai YZ, Li XM, Zhou Y, Ma L, Feng GH.
    Intervirology; 2009 Nov 12; 52(3):152-63. PubMed ID: 19521104
    [Abstract] [Full Text] [Related]

  • 10. An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response.
    Hu XD, Chen ST, Li JY, Yu DH, Yi-Zhang, Cai H.
    Vaccine; 2010 Mar 11; 28(12):2408-15. PubMed ID: 20064480
    [Abstract] [Full Text] [Related]

  • 11. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 11; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan 11; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 13. Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine.
    Roos AK, Pavlenko M, Charo J, Egevad L, Pisa P.
    Prostate; 2005 Feb 15; 62(3):217-23. PubMed ID: 15389792
    [Abstract] [Full Text] [Related]

  • 14. [Enhanced inhibitory effect of MUC1 gene vaccine on breast cancer growth by GM-CSF].
    Yuan SF, Li KZ, Wang L, Yan Z, Han W, Zhang YQ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov 15; 20(6):737-40. PubMed ID: 15555449
    [Abstract] [Full Text] [Related]

  • 15. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L, Kedl R, Dow S.
    Cancer Gene Ther; 2006 Nov 15; 13(11):1033-44. PubMed ID: 16841080
    [Abstract] [Full Text] [Related]

  • 16. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
    Lladser A, Párraga M, Quevedo L, Carmen Molina M, Silva S, Ferreira A, Billetta R, G Quest AF.
    Immunobiology; 2006 Nov 15; 211(1-2):11-27. PubMed ID: 16446167
    [Abstract] [Full Text] [Related]

  • 17. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2.
    Rittich S, Duskova M, Mackova J, Pokorna D, Jinoch P, Smahel M.
    Oncol Rep; 2005 Feb 15; 13(2):311-7. PubMed ID: 15643517
    [Abstract] [Full Text] [Related]

  • 18. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
    Zhang X, Divangahi M, Ngai P, Santosuosso M, Millar J, Zganiacz A, Wang J, Bramson J, Xing Z.
    Vaccine; 2007 Jan 26; 25(7):1342-52. PubMed ID: 17052817
    [Abstract] [Full Text] [Related]

  • 19. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H, Attanucci J, Giezeman-Smits KM, Brissette-Storkus C, Fellows WK, Gambotto A, Pollack LF, Pogue-Geile K, Lotze MT, Bozik ME, Chambers WH.
    Cancer Res; 2001 Mar 15; 61(6):2625-31. PubMed ID: 11289140
    [Abstract] [Full Text] [Related]

  • 20. Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine.
    Chen SA, Tsai MH, Wu FT, Hsiang A, Chen YL, Lei HY, Tzai TS, Leung HW, Jin YT, Hsieh CL, Hwang LH, Lai MD.
    Clin Cancer Res; 2000 Nov 15; 6(11):4381-8. PubMed ID: 11106257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.